Intimation of Earning Concall under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations. 2015.
3BBLACKBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
3B BlackBio Dx Ltd has informed the stock exchanges that it will hold an earnings conference call for investors and analysts on Wednesday, February 18, 2026 at 4:00 PM IST. The call will cover the company's operational and financial performance for the quarter and nine months ended December 31, 2025 (Q3 FY26). The call will be addressed by Chairman & Managing Director Dhirendra Dubey and Whole Time Director Nikhil Kuber Dubey, with Nuvama Wealth Research coordinating. Dial-in numbers for India, USA, UK, Singapore, and Hong Kong have been shared.
This is a routine disclosure informing the market about an upcoming earnings call — no new financial figures or business developments are shared here. Investors should watch the call on February 18 for actual Q3 FY26 performance details that could move the stock.